- Home
- FRGT vs VBIO Comparison
FRGT vs VBIO Comparison
Compare FRGT & VBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRGT | VBIO |
|---|---|---|
| Founded | 2015 | N/A |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6M | 1.6M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FRGT | VBIO |
|---|---|---|
| Price | $1.45 | $0.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 222.3K | ★ 22.2M |
| Earning Date | 05-20-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.85 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,728,922.00 | $780,000.00 |
| Revenue This Year | $371.03 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.50 | $0.11 |
| 52 Week High | $5.90 | $4.14 |
Technical Indicators
Market Signals| Indicator | FRGT | VBIO |
|---|---|---|
| Relative Strength Index (RSI) | 31.67 | 47.35 |
| Support Level | $1.49 | N/A |
| Resistance Level | $1.77 | $0.48 |
| Average True Range (ATR) | 0.29 | 0.44 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 9.07 | 0.22 |
Price Performance
Historical ComparisonAbout FRGT Freight Technologies Inc.
Freight Technologies Inc is a technology company developing solutions to optimize and automate the supply chain process. Along with its subsidiary, Freight App, Inc, the group is focused on making shipping transparent and efficient. Fr8App provides carriers with increased growth opportunities and shippers with flexibility, visibility, and simplicity for the once-complex process of international over-the-road (OTR) shipping. The company uses its proprietary technology platform to connect carriers and shippers and significantly improve matching and operation efficiency via technologies such as live pricing and real-time tracking, digital freight marketplace, broker, transportation management, fleet management, and committed capacity solutions.
About VBIO Valion Bio Inc. Common Stock
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.